Literature DB >> 24896785

Limited activity and social participation after hospital discharge from leprosy treatment in a hyperendemic area in North Brazil.

Lorena Dias Monteiro1, Carlos Henrique Alencar1, Jaqueline Caracas Barbosa1, Candice Cristiane Barros Santana Novaes2, Rita de Cássia Pereira da Silva3, Jorg Heukelbach1.   

Abstract

INTRODUCTION: Neural damages are among the main factors that contribute to physical disability in leprosy. Systematic monitoring using a broad physical, psychological and social approach is necessary.
OBJECTIVE: The objective of this study was to characterize the limitation of activity and social participation and its correlation with disabilities and/or impairment in individuals after being discharged from a multidrug leprosy therapy.
METHOD: A cross-sectional study conducted in Araguaína, state of Tocantins, which is a leprosy hyperendemic municipality. We included cases of patients who were discharged from treatment considered as cured from January 2004 to December 2009. We performed dermatological examination and applied the Screening Activity Limitation and Safety Awareness (SALSA) and social participation scales.
RESULTS: We included 282 individuals (mean age: 45.8 years old). The paucibacillary operational classification was more common (170; 60.3%). The eye-hand-foot score ranged from 0 to 12 (mean: 0.7). A total of 84 (29.8%) individuals presented limited activity. A slight restriction in social participation occurred in 18 (6.3%) cases. There was a statistically significant correlation between activity limitation, age (r = 0.40; p < 0.0001) and degree of functional limitation (r = 0.54; p < 0.0001), as well as of restricted social participation, activity limitation (r = 0.56, p < 0.0001) and functional limitations (r = 0.54, p < 0.0001).
CONCLUSION: Functional limitation due to leprosy had an impact on the conduct of activities and social participation after the discharge from a leprosy treatment. The association between Screening of Activity Limitation and Safety Awareness and participation scales will assist in designing evidence-based assistance measures.

Entities:  

Mesh:

Year:  2014        PMID: 24896785     DOI: 10.1590/1415-790x201400010008eng

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  7 in total

1.  Myelination key factor krox-20 is downregulated in Schwann cells and murine sciatic nerves infected by Mycobacterium leprae.

Authors:  Mariane Bertolucci Casalenovo; Patrícia Sammarco Rosa; Daniele Ferreira de Faria Bertoluci; Adriana Sierra Assencio Almeida Barbosa; Dejair Caitano do Nascimento; Vânia Nieto Brito de Souza; Maria Renata Sales Nogueira
Journal:  Int J Exp Pathol       Date:  2019-05-14       Impact factor: 1.925

2.  Functional Activity Limitation and Quality of Life of Leprosy Cases in an Endemic Area in Northeastern Brazil.

Authors:  Victor S Santos; Laudice S Oliveira; Fabrícia D N Castro; Vanessa T Gois-Santos; Ligia M D Lemos; Maria do C O Ribeiro; Luis E Cuevas; Ricardo Q Gurgel
Journal:  PLoS Negl Trop Dis       Date:  2015-07-01

3.  Factors associated with the development of physical disabilities in Hansen's disease.

Authors:  Emanuelle Malzac Freire de Santana; Karen Krystine Gonçalves de Brito; Ester Missias Vilaverde Antas; Jordana de Almeida Nogueira; Oriana Deyze Correia Paiva Leadebal; Mirian Alves da Silva; Marta Miriam Lopes Costa; Maria Júlia Guimarães Oliveira Soares
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-06-28       Impact factor: 1.846

4.  Disability progression among leprosy patients released from treatment: a survival analysis.

Authors:  Aleksandra Rosendo Dos Santos; Pãmela Rodrigues de Souza Silva; Peter Steinmann; Eliane Ignotti
Journal:  Infect Dis Poverty       Date:  2020-05-24       Impact factor: 4.520

5.  Spatial patterns of leprosy in a hyperendemic state in Northern Brazil, 2001-2012.

Authors:  Lorena Dias Monteiro; Francisco Rogerlândio Martins-Melo; Aline Lima Brito; Carlos Henrique Alencar; Jorg Heukelbach
Journal:  Rev Saude Publica       Date:  2015-11-24       Impact factor: 2.106

6.  Grade 2 disabilities in leprosy patients from Brazil: Need for follow-up after completion of multidrug therapy.

Authors:  Marcos Túlio Raposo; Martha Cerqueira Reis; Ana Virgínia de Queiroz Caminha; Jörg Heukelbach; Lucy Anne Parker; Maria Pastor-Valero; Maria Ines Battistella Nemes
Journal:  PLoS Negl Trop Dis       Date:  2018-07-16

7.  The impact of podoconiosis, lymphatic filariasis, and leprosy on disability and mental well-being: A systematic review.

Authors:  Oumer Ali; Asrat Mengiste; Maya Semrau; Abraham Tesfaye; Abebaw Fekadu; Gail Davey
Journal:  PLoS Negl Trop Dis       Date:  2021-07-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.